GAUK 254923 The Relation of de novo lipogenesis and peroxisomal metabolism in obesity (PEROXI) 2024–2026

AZV ČR NU21-01-00469 Novel approaches to enhance insulin-sensitizing effects of exercise: targeting PAHSA metabolism (ETAPA) 2021-2025

H2020 SC1-BHC-07-2019, Project # 874708 Gene therapy to restore lymphatic flow in lymphedema (THERALYMPH) 2020-2025

AZV ČR NU20J-01-00005 The ketogenic diet as a modulator of de novo lipogenesis in the liver and visceral fat mass (KETOLIVA)

AZV ČR NV19-01-00263 The role of de novo lipogenesis in adipose tissue in the regulation of insulin sensitivity in obese individuals (DELISA)

AZV ČR NV19-01-00101 The pancreatic cancer: metabolic changes associated with insulin resistance (PAMIR)

AZV ČR 16-29182A Effect of exercise training and omega-3 fatty acids on metabolic health and dysfunction of adipose tissue in elderly (EXODYA) 2016-2019

GAČR 16-14048S Limited adipose tissue expandability as a risk factor for development of type 2 diabetes: the role of preadipocytes (LIMEX) 2016-2018

GAČR 16-00477S Lymphatic stasis as a modulator of adipose tissue expansion and inflammation (LYMPHAT) 2016-2018

IGA MZ ČR The role of fatty acids in the regulation of adipose tissue immune status 2013-2015

GAČR P301/11/0748 The role of endoplasmic reticulum stress in the pathogenesis of obesity-related inflammation in human adipose tissue 2010-2013

FP7 Health-2007-A Adipokines as drug targets to combat adverse effects of excess adipose tissue 2008-2012